Trial Profile
A first-in-human clinical trial of Birch pollen allergy vaccine
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 02 Nov 2018
Price :
$35
*
At a glance
- Drugs Birch pollen allergy immunotherapy (Primary)
- Indications Tree pollen hypersensitivity
- Focus First in man; Therapeutic Use
- 02 Nov 2018 New trial record
- 29 Oct 2018 According to a Desentum media release, this trial is scheduled to start in autumn 2019.